We are live on ! Find out more
ANIP icon

ANI Pharmaceuticals
ANIP

126 hedge funds and large institutions have $434M invested in ANI Pharmaceuticals in 2015 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 42 increasing their positions, 32 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

307% more call options, than puts

Call options by funds: $12.2M | Put options by funds: $3M

192% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 13

37% more capital invested

Capital invested by funds: $317M → $434M (+$117M)

31% more repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 32

25% more funds holding

Funds holding: 101 → 126 (+25)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
126
Holders Change
+25
Holders Change %
+24.75%
% of All Funds
3.36%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
38
Increased
42
Reduced
32
Closed
13
Calls
$12.2M
Puts
$3M
Net Calls
+$9.2M
Net Calls Change
+$8.64M

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$18.4M
2
BFA
BlackRock Fund Advisors
California
+$17.1M
3
Invesco
Invesco
Georgia
+$13.6M
4
Nomura Holdings
Nomura Holdings
Japan
+$8.43M
5
Millennium Management
Millennium Management
New York
+$7.05M

Top Sellers

Rank Fund Capital Flow
1
Wells Fargo
Wells Fargo
California
-$5.74M
2
FIM
Foresters Investment Management
New York
-$5.2M
3
MOACM
Mutual of America Capital Management
New York
-$4.25M
4
AQR Capital Management
AQR Capital Management
Connecticut
-$3.9M
5
EI
EAM Investors
California
-$3.12M
Name Holding Trade Value Shares
Change 		Change in
Stake
Principal Financial Group
26
Principal Financial Group
Iowa
$3.18M +$3.09M +50,804 New
JAM
27
JW Asset Management
Florida
$3.16M +$1.7M +28,029 +124%
HHC
28
Hutchin Hill Capital
New York
$3.1M +$3.01M +49,500 New
Geode Capital Management
29
Geode Capital Management
Massachusetts
$3.07M +$146K +2,402 +5%
RFC
30
Russell Frank Company
Washington
$2.88M -$1.75M -28,851 -39%
GCP
31
GSA Capital Partners
United Kingdom
$2.86M -$1.64K -27 -0.1%
Fidelity Investments
32
Fidelity Investments
Massachusetts
$2.83M +$2.75M +45,200 New
AQR Capital Management
33
AQR Capital Management
Connecticut
$2.68M -$3.9M -64,100 -60%
Ohio Public Employees Retirement System (OPERS)
34
Ohio Public Employees Retirement System (OPERS)
Ohio
$2.67M +$2.6M +42,700 New
CAM
35
ClariVest Asset Management
California
$2.54M +$123K +2,026 +5%
GAM
36
Gotham Asset Management
New York
$2.42M +$2.1M +34,594 +847%
DC
37
Deere & Company
Illinois
$2.4M +$1.82M +29,971 +354%
MAA
38
Managed Account Advisors
New Jersey
$2.36M +$410K +6,746 +22%
D.E. Shaw & Co
39
D.E. Shaw & Co
New York
$2.3M +$1.43M +23,429 +175%
SG Americas Securities
40
SG Americas Securities
New York
$2.24M +$1.46M +23,949 +203%
California Public Employees Retirement System
41
California Public Employees Retirement System
California
$2.19M – – –
CCM
42
Century Capital Management
Massachusetts
$2.15M +$2.1M +34,451 New
TCIM
43
TIAA CREF Investment Management
New York
$2.09M -$17.4K -286 -0.9%
SCM
44
Sarissa Capital Management
Connecticut
$1.94M – – –
MOACM
45
Mutual of America Capital Management
New York
$1.55M -$4.25M -69,868 -74%
BIM
46
BlackRock Investment Management
Delaware
$1.53M +$298K +4,891 +25%
Barclays
47
Barclays
United Kingdom
$1.28M +$1.2M +19,703 +2,107%
Prudential Financial
48
Prudential Financial
New Jersey
$1.16M +$1.13M +18,530 New
Goldman Sachs
49
Goldman Sachs
New York
$1.13M +$1.1M +18,089 New
PP
50
PDT Partners
New York
$1.08M -$152K -2,500 -13%
1
2
3 4 5

ANIP Hedge Fund Activity: Q1 2015 in Review

126 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in ANI Pharmaceuticals (ANIP) for Q1 2015, worth a combined $434M — up 37% from $317M a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new ANIP positions and 13 closed out — a net gain of 25 holders — while 42 added to existing stakes and 32 trimmed.

The largest buyer was State Street, adding an estimated $18.4M. The largest seller was Wells Fargo, cutting an estimated $5.74M.

  • 126 institutional investors held ANI Pharmaceuticals (ANIP) as of Q1 2015, up from 101 in Q4 2014.
  • Funds reported $434M of ANI Pharmaceuticals stock for Q1 2015, up 37% quarter-over-quarter.
  • 38 funds opened new ANI Pharmaceuticals positions in Q1 2015 and 13 closed out, a net change of +25 holders.
  • The largest ANI Pharmaceuticals buyer in Q1 2015 was State Street, an estimated $18.4M added.
  • The largest ANI Pharmaceuticals seller in Q1 2015 was Wells Fargo, an estimated $5.74M sold.

Based on aggregated 13F filings for Q1 2015.